Product Information
DASATINIB 100 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $26.1835 per EA under NDC 00480510456. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Aug 27, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480510456
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DASATINIBApproval Type
Generic (ANDA)
FDA Application
ANDA211094FDA Approved
8/27/2025
TE Code
AB
On Market Since
9/18/2025
Pharmacological Classes
Price Statistics
The NADAC for DASATINIB 100 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.1835 per EA |
|---|---|
| All-time high | $191.7363 (Dec 10, 2025) |
| All-time low | $26.1835 (Aug 19, 2026) |
| 52-week high | $191.7363 |
| 52-week low | $26.1835 |
| Median price | $29.1857 |
| Average price | $51.6863 |
| Largest weekly change | -84.2% (Dec 17, 2025) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DASATINIB 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DASATINIB 100 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $26.1835 per EA (NDC 00480510456), effective Aug 19, 2026.
How has the price of DASATINIB 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for DASATINIB 100 MG TABLET has declined 86.3%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for DASATINIB 100 MG TABLET?
Since Nov 5, 2025, the NADAC for DASATINIB 100 MG TABLET has ranged from a low of $26.1835 (Aug 19, 2026) to a high of $191.7363 (Dec 10, 2025), with a median of $29.1857 per EA.
Are there cheaper alternatives to DASATINIB 100 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DASATINIB 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DASATINIB 100 MG TABLET?
DASATINIB 100 MG TABLET (NDC 00480510456) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.